COVID Test Kits from Honeyman Assured Screening

High accuracy, rapid turnaround COVID-19 Active Virus PCR Screening and Antibody Testing, UK & Ireland

Visit www.assuredscreening.com to enquire and buy a test kit.

Assured ScreeningBecome a Clinical Partner | PCR ScreeningBusiness Solutions

High accuracy, rapid turnaround COVID-19
Antibody Screening, UK & Ireland

Click here to enquire and buy Antibody Test from Honeyman Assured Screening

Launch of MosaiQ™ Antibody Testing Platform for COVID-19

High accuracy, rapid turnaround COVID-19 antibody testing in UK & Ireland

Honeyman now offers a highly sensitive antibody test utilising Quotient’s high-throughput MosaiQ™ platform.  

Tests will be available across the UK and Ireland via our network of Assured Screening clinical test partners from Monday 29th June 2020. 

This is in addition to and complements PCR screening for active COVID-19 infection.

High accuracy, rapid turnaround COVID-19 antibody testing across UK & Ireland:

  • Dual Antibody Detection
  • Detects at an Early Stage of Infection
  • IgG and IgM Response Detection to SARS-CoV-2
  • High Accuracy COVID-19 Antibody Test
  • Best in Class in IgG and IgM Detection
  • Rapid Turnaround - Result to Clinic in 24 hours of Sample Receipt

Photo: MosaiQ™ antibody analysis in operation

The Test

The test is designed to detect both IgG and IgM response to SARS-CoV-2 at an early stage of infection. Studies evidence people can be IgM positive while not IgG positive.

Detecting antibodies with 100% sensitivity, the MosaiQ™ equipment can process up to 3,000 samples a day utilising Honeyman’s sample collection network. The company is the only laboratory to provide antibody and PCR sample turnaround in less than 24 hours from collection throughout the UK and Republic of Ireland. 

“Dual antibody detection is a significant step forward. Existing approved test methods used within the UK only provide for IgG antibody detection, but research has shown that not everyone has this reaction. Quotient’s MosaiQ™ COVID-19 Antibody Microarray additionally picks-up the instances in which people have an IgM response.” Tom Honeyman Managing Director, Honeyman Group

This CE-IVD certified COVID antibody test is available throughout the UK and Ireland via our network of specialist phlebotomy partners.  Already available in the US, Switzerland, Denmark, Spain, France and the United States, now launching in UK and Ireland.

Clinical Utility

MosaiQ Brochure Quotient

Brochure Download:

The MosaiQ™ COVID-19 Antibody Microarray was CE marked on 01 May 2020. With a 100% sensitivity and 99.8% specificity claim, the test has a best in class performance. 

The MosaiQ instrument has all relevant medical diagnostic device approvals and the microarray manufacturing facility is ISO 13485 certified.

  • 100% Sensitivity
  • 99.8% Specificity
  • ISO 13485 Certified
  • CE-IVD Approved 

Benefits of COVID-19 Antibody Testing

Antibody testing is important as it can indicate the presence of Covid-19 related antibodies resulting from past or recent infection, allowing immunity rates to be assessed. Using COVID-19 antibody testing solutions to assess an individual’s potential immunity to the disease can help clinicians ultimately determine who can return to work and daily life amid the COVID-19 pandemic.

‘Antibody testing – the ability to quickly test if people have developed antibodies to COVID-19– is critical in helping the UK move out of lockdown, restarting the economy and continuing to fight this pandemic. We are proud to be working with Honeyman.'  Franz Walt Chief Executive Officer, Quotient

As the COVID-19 pandemic continues to disrupt every aspect of normality, affecting millions worldwide, Honeyman Group is committed to help those with immunity return to work, particularly healthcare workers on the frontline.

Who can benefit from IgG and IgM Antibody Testing?

Particularly working with businesses looking to safeguard staff. Our partners throughout the UK and Ireland will service taking bloods and return samples through independent regional surgeries.

‘MosaiQ was developed in the UK, in Edinburgh, and Switzerland and we believe it is one of the most accurate and fastest tests on the market. We are talking to Governments and laboratories across the Continent and are delighted about the positive response we have been getting’, Ed Farrell Chief Operating Officer, Quotient.

Find Clinical Partners – COVID Antibody testing near you

Clinical Partners Test Network

Our Clinical Partners

Please note we are not able to service direct requests for testing.  

All enquiries must be directed through one of our private medical partners in the UK and Ireland.

We invite suitably qualified organisations throughout the UK and Ireland to join our professional test network.

Become a Partner – Invitation to join our Test Network Providers Register

Contact Us

Our Customers:

Testimonial Testimonial Testimonial Testimonial Testimonial Testimonial Testimonial Testimonial Testimonial Testimonial Testimonial Testimonial Testimonial Testimonial Testimonial Testimonial Testimonial

Web Enquiry Form